Glycemic Control in Patients With Type 2 Diabetes Mellitus With a Disease‐Specific Enteral Formula: Stage II of a Randomized, Controlled Multicenter Trial

Abstract

Long-term tube feeding with a disease-specific enteral formula was safe and well tolerated in type 2 diabetic patients with neurological disorders. When compared with a standard diet, TI requirement decreased significantly with less hypoglycemia whereas FG and AG were significantly lowered, resulting in improved glycemic control.